+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opioid Analgesics Market - Global Forecast 2026-2032- Product Image
Opioid Analgesics Market - Global Forecast 2026-2032- Product Image
Sale

Opioid Analgesics Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6157940
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Opioid Analgesics Market is projected to reach USD 22.13 Billion in 2026. It is expected to continue growing at a CAGR of 7.19%, reaching USD 33.57 Billion by 2032.

Opioid Analgesics: Executive Summary

Opioid analgesics are prescription medicines used primarily for moderate-to-severe pain, including acute postoperative pain, cancer-related pain, and selected chronic pain conditions. Their clinical value is balanced by risks such as respiratory depression, tolerance, dependence, misuse, and overdose. The market is therefore shaped not only by therapeutic demand, but also by prescribing standards, controlled-substance regulation, public-health policy, treatment access, and the availability of non-opioid alternatives.

Policy, Safety, and Care-Model Shifts Are Reshaping Use

The landscape is moving toward more cautious, indication-specific prescribing and stronger monitoring across the treatment pathway. Regulators and health systems increasingly emphasize informed consent, prescription-drug monitoring, limits on duration and quantity where appropriate, safe storage and disposal, overdose education, and access to medicines for opioid-use disorder. At the same time, hospitals and clinicians are expanding multimodal pain management that combines non-opioid medicines, regional anesthesia, physical rehabilitation, behavioral care, and other supportive interventions. These changes create a more differentiated environment in which clinical appropriateness, supply reliability, and responsible-use systems are central to adoption.

Artificial Intelligence Supports Safer, More Individualized Pain Care

Artificial intelligence can assist with clinical documentation, risk stratification, prescribing review, adverse-event surveillance, and identification of patients who may benefit from earlier intervention. Predictive tools may help health systems detect unusual prescribing patterns, support follow-up prioritization, and improve coordination between pain care, primary care, pharmacy services, and addiction treatment. However, these applications require representative data, transparent validation, privacy safeguards, human oversight, and careful management of bias. AI should support-not replace-clinical judgment, patient communication, and established controlled-substance governance.

Regional Insights: Regulation and Access Vary Across Six Geographies

North America remains highly focused on opioid-related harm reduction, prescribing oversight, treatment access, and naloxone availability. Europe generally combines controlled-medicine regulation with structured healthcare pathways, while differences in national guidelines and access persist. Asia-Pacific includes mature pharmaceutical systems alongside rapidly expanding healthcare capacity, producing varied approaches to pain management and opioid stewardship. Latin America faces uneven access to essential analgesia, regulatory complexity, and differing public-health capacity. The Middle East is influenced by national medicine controls, specialist-care availability, and efforts to improve cancer and palliative pain services. Africa continues to address limited access to essential pain medicines, supply and workforce constraints, and the need to strengthen both palliative care and prevention of misuse.

Group Insights: Multilateral and Economic Blocs Need Coordinated Stewardship

ASEAN members face diverse regulatory systems, healthcare capacity, and access conditions, making regional coordination valuable for procurement, training, and safe prescribing. BRICS countries span substantial differences in disease burden, manufacturing capability, regulation, and treatment access, with opportunities to strengthen shared public-health learning. The European Union benefits from cross-border policy dialogue while retaining national differences in reimbursement and clinical practice. G7 countries generally have advanced monitoring and clinical infrastructure but continue to address opioid-related harms and equitable access to treatment. GCC states are strengthening specialized healthcare capacity while maintaining tightly controlled medicine channels. NATO members include varied health systems and should prioritize common readiness, trauma-care protocols, and continuity of essential medicines without weakening stewardship safeguards.

Country Insights: National Systems Shape Opioid Analgesic Use

Australia and Canada combine established pain-care systems with strong attention to opioid stewardship and harm reduction. Brazil, Mexico, India, and South Africa face the dual challenge of improving access to appropriate analgesia while strengthening controls, workforce capability, and treatment for opioid-related disorders. China, Japan, and South Korea have distinct regulatory and clinical traditions, with growing emphasis on safe prescribing and access for serious illness. France, Germany, Italy, Spain, and the United Kingdom operate within mature healthcare frameworks, yet differ in reimbursement, prescribing guidance, palliative-care provision, and monitoring arrangements. Russia’s controlled-medicine environment and healthcare access patterns also shape availability and clinical use. Across the United States, intensive policy and clinical attention remains focused on overdose prevention, prescribing safety, treatment access, and balancing legitimate pain care with misuse prevention.

Industry Priorities: Build Safety, Access, and Evidence Into Every Offering

Leaders should align products and services with clearly defined indications, evidence-based dosing guidance, and transparent risk communication. Investment should prioritize tamper-resistant and abuse-deterrent approaches where clinically justified, reliable supply of essential medicines, clinician education, and partnerships that expand non-opioid and multimodal care. Organizations should strengthen pharmacovigilance, prescription-monitoring interoperability, patient screening and follow-up, naloxone access, and referral pathways for opioid-use disorder. Regional strategies should be adapted to local regulation and access constraints rather than copied across markets. AI initiatives should begin with narrow, measurable use cases and independent validation, while governance teams continuously assess safety, equity, privacy, and clinical accountability.

Research Methodology: Evidence-Based Review of Clinical and Policy Drivers

This executive summary uses a qualitative, structured assessment of opioid analgesics as a therapeutic category. The approach considers clinical indications, safety risks, prescribing and dispensing controls, pain-management practice, public-health interventions, healthcare-system capacity, and regional regulatory variation. Insights are synthesized across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, and then contextualized for ASEAN, BRICS, the European Union, the G7, the GCC, NATO, and the specified countries. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used.

Conclusion: Responsible Access Must Guide the Next Phase

Opioid analgesics will remain clinically important where severe pain requires potent treatment, but their role is increasingly defined by careful patient selection, monitoring, integrated care, and harm reduction. Progress depends on balancing access for legitimate medical need with prevention of misuse, diversion, dependence, and overdose. Industry leaders that combine credible evidence, resilient supply, responsible innovation, and collaboration with clinicians, regulators, pharmacists, and public-health systems will be best positioned to support safer and more equitable pain care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Opioid Analgesics Market, by Opioid Type
7.1. Introduction
7.2. Natural Opioids
7.2.1. Morphine
7.2.2. Codeine
7.2.3. Thebaine
7.3. Semi Synthetic Opioids
7.3.1. Oxycodone
7.3.2. Hydrocodone
7.3.3. Oxymorphone
7.4. Fully Synthetic Opioids
7.4.1. Fentanyl
7.4.2. Methadone
7.4.3. Meperidine
7.4.4. Tramadol
7.4.5. Buprenorphine
8. Opioid Analgesics Market, by Route Of Administration
8.1. Introduction
8.2. Oral
8.2.1. Capsule
8.2.2. Tablet
8.2.3. Oral Solution
8.3. Transdermal
8.4. Parenteral
8.4.1. Intravenous
8.4.2. Intramuscular
8.4.3. Subcutaneous
8.5. Buccal & Sublingual
8.5.1. Buccal Tablet
8.5.2. Sublingual Tablet
8.5.3. Buccal Film
9. Opioid Analgesics Market, by Formulation Type
9.1. Introduction
9.2. Immediate Release
9.3. Immediate Release
9.3.1. Oral Immediate Release
9.3.2. Parenteral Immediate Release
9.4. Extended Release
10. Opioid Analgesics Market, by Indication
10.1. Introduction
10.2. Acute Pain
10.3. Cancer Pain
10.4. Chronic Pain
11. Opioid Analgesics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Opioid Analgesics Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Opioid Analgesics Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Opioid Analgesics Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Akorn Inc.
16.3. Alembic Pharmaceuticals Ltd
16.4. Aurobindo Pharma Limited
16.5. Bausch Health Companies Inc.
16.6. Cadila Healthcare Ltd
16.7. Collegium Pharmaceutical Inc.
16.8. Daiichi Sankyo Company, Limited
16.9. Dr. Reddy’s Laboratories Ltd
16.10. Endo International plc
16.11. GlaxoSmithKline plc
16.12. Grünenthal GmbH
16.13. Hikma Pharmaceuticals plc
16.14. Johnson & Johnson
16.15. Lupin Limited
16.16. Mallinckrodt Pharmaceuticals plc
16.17. Mayne Pharma Group Ltd
16.18. Mundipharma Pharmaceuticals
16.19. Pfizer Inc.
16.20. Purdue Pharma L.P.
16.21. Sanofi SA
16.22. Sterling Pharma Solutions (UK) Ltd
16.23. Sun Pharmaceutical Industries Ltd.
16.24. Teva Pharmaceutical Industries Ltd.
16.25. Viatris Inc.
16.26. Zoetis Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Opioid Analgesics Market, Years Considered for the Study
FIGURE 2. Global Opioid Analgesics Market, Research Design
FIGURE 3. Global Opioid Analgesics Market, Research Framework
FIGURE 4. Global Opioid Analgesics Market, Data Triangulation
FIGURE 5. Global Opioid Analgesics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Opioid Analgesics Market Size, by Opioid Type, 2025 vs 2032 (%)
FIGURE 7. Global Opioid Analgesics Market Size, by Opioid Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Opioid Analgesics Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Opioid Analgesics Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Opioid Analgesics Market Size, by Formulation Type, 2025 vs 2032 (%)
FIGURE 11. Global Opioid Analgesics Market Size, by Formulation Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Opioid Analgesics Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Opioid Analgesics Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Opioid Analgesics Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Opioid Analgesics Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Opioid Analgesics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Opioid Analgesics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Opioid Analgesics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Opioid Analgesics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Opioid Analgesics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Opioid Analgesics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Opioid Analgesics Market Segmentation & Coverage
TABLE 2. Global Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 4. Global Natural Opioids Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Natural Opioids Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Natural Opioids Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Morphine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Morphine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Morphine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Codeine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Codeine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Codeine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Thebaine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Thebaine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Thebaine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Semi Synthetic Opioids Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Semi Synthetic Opioids Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Semi Synthetic Opioids Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Oxycodone Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Oxycodone Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Oxycodone Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Hydrocodone Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Hydrocodone Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Hydrocodone Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Oxymorphone Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Oxymorphone Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Oxymorphone Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Fully Synthetic Opioids Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Fully Synthetic Opioids Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Fully Synthetic Opioids Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Fentanyl Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Fentanyl Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Fentanyl Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Methadone Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Methadone Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Methadone Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Meperidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Meperidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Meperidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Tramadol Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Tramadol Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Tramadol Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Buprenorphine Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Buprenorphine Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Buprenorphine Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 47. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Oral Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Oral Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Oral Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Transdermal Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Transdermal Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Transdermal Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Buccal & Sublingual Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Buccal & Sublingual Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Buccal & Sublingual Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Buccal Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Buccal Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Buccal Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Sublingual Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Sublingual Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Sublingual Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Buccal Film Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Buccal Film Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Buccal Film Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 87. Global Immediate Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Immediate Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Immediate Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Immediate Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Immediate Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Immediate Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Oral Immediate Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Oral Immediate Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Oral Immediate Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Parenteral Immediate Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Parenteral Immediate Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Parenteral Immediate Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Extended Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Extended Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Extended Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 103. Global Acute Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Acute Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Acute Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Cancer Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Cancer Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Cancer Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Chronic Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Chronic Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Chronic Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. North America Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. North America Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 138. North America Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 139. North America Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 140. North America Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 141. North America Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 142. North America Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 143. North America Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 144. North America Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 145. North America Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 146. North America Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 147. North America Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 148. North America Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. Latin America Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Latin America Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 151. Latin America Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 152. Latin America Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 153. Latin America Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 154. Latin America Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 155. Latin America Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 156. Latin America Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 157. Latin America Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 158. Latin America Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 159. Latin America Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 160. Latin America Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 161. Latin America Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Europe Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Europe Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 164. Europe Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 165. Europe Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 166. Europe Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 167. Europe Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 168. Europe Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 169. Europe Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 170. Europe Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 171. Europe Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 172. Europe Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 173. Europe Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 174. Europe Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Middle East Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Middle East Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 177. Middle East Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 178. Middle East Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 179. Middle East Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 180. Middle East Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 181. Middle East Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 182. Middle East Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 183. Middle East Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 184. Middle East Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 185. Middle East Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 186. Middle East Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 187. Middle East Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Africa Opioid Analgesics Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Africa Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 190. Africa Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 191. Africa Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 192. Africa Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 193. Africa Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 194. Africa Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 195. Africa Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 196. Africa Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 197. Africa Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 198. Africa Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 199. Africa Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 200. Africa Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. Global Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. ASEAN Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. ASEAN Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 204. ASEAN Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 205. ASEAN Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 206. ASEAN Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 207. ASEAN Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 208. ASEAN Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 209. ASEAN Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 210. ASEAN Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 211. ASEAN Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 212. ASEAN Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 213. ASEAN Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 214. ASEAN Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. GCC Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. GCC Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 217. GCC Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 218. GCC Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 219. GCC Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 220. GCC Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 221. GCC Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 222. GCC Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 223. GCC Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 224. GCC Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 225. GCC Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 226. GCC Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 227. GCC Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. European Union Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. European Union Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 230. European Union Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 231. European Union Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 232. European Union Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 233. European Union Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 234. European Union Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 235. European Union Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 236. European Union Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 237. European Union Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 238. European Union Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 239. European Union Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 240. European Union Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. BRICS Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. BRICS Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 243. BRICS Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 244. BRICS Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 245. BRICS Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 246. BRICS Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 247. BRICS Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 248. BRICS Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 249. BRICS Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 250. BRICS Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 251. BRICS Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 252. BRICS Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 253. BRICS Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. G7 Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. G7 Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 256. G7 Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 257. G7 Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 258. G7 Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 259. G7 Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 260. G7 Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 261. G7 Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 262. G7 Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 263. G7 Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 264. G7 Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 265. G7 Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 266. G7 Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 267. NATO Opioid Analgesics Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. NATO Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 269. NATO Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 270. NATO Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 271. NATO Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 272. NATO Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 273. NATO Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 274. NATO Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 275. NATO Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 276. NATO Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 277. NATO Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 278. NATO Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 279. NATO Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. Global Opioid Analgesics Market Size, by Country, 2017-2032 (USD Million)
TABLE 281. United States Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 282. United States Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 283. United States Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 284. United States Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 285. United States Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 286. United States Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 287. United States Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 288. United States Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 289. United States Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 290. United States Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 291. United States Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 292. United States Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 293. United States Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 294. Canada Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 295. Canada Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 296. Canada Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 297. Canada Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 298. Canada Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 299. Canada Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 300. Canada Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 301. Canada Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 302. Canada Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 303. Canada Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 304. Canada Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 305. Canada Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 306. Canada Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Mexico Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 308. Mexico Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 309. Mexico Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 310. Mexico Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 311. Mexico Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 312. Mexico Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 313. Mexico Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 314. Mexico Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 315. Mexico Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 316. Mexico Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 317. Mexico Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 318. Mexico Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 319. Mexico Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 320. Brazil Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 321. Brazil Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 322. Brazil Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 323. Brazil Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 324. Brazil Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 325. Brazil Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 326. Brazil Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 327. Brazil Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 328. Brazil Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 329. Brazil Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 330. Brazil Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 331. Brazil Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 332. Brazil Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 333. United Kingdom Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 334. United Kingdom Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 335. United Kingdom Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 336. United Kingdom Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 337. United Kingdom Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 338. United Kingdom Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 339. United Kingdom Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 340. United Kingdom Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 341. United Kingdom Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 342. United Kingdom Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 343. United Kingdom Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 344. United Kingdom Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 345. United Kingdom Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 346. Germany Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 347. Germany Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 348. Germany Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 349. Germany Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 350. Germany Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 351. Germany Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 352. Germany Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 353. Germany Opioid Analgesics Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 354. Germany Opioid Analgesics Market Size, by Buccal & Sublingual, 2017-2032 (USD Million)
TABLE 355. Germany Opioid Analgesics Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 356. Germany Opioid Analgesics Market Size, by Immediate Release, 2017-2032 (USD Million)
TABLE 357. Germany Opioid Analgesics Market Size, by Indication, 2017-2032 (USD Million)
TABLE 358. Germany Opioid Analgesics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 359. France Opioid Analgesics Market Size, 2017-2032 (USD Million)
TABLE 360. France Opioid Analgesics Market Size, by Opioid Type, 2017-2032 (USD Million)
TABLE 361. France Opioid Analgesics Market Size, by Natural Opioids, 2017-2032 (USD Million)
TABLE 362. France Opioid Analgesics Market Size, by Semi Synthetic Opioids, 2017-2032 (USD Million)
TABLE 363. France Opioid Analgesics Market Size, by Fully Synthetic Opioids, 2017-2032 (USD Million)
TABLE 364. France Opioid Analgesics Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 365. France Opioid Analgesics Market Size, by Oral, 2017-2032 (USD Million)
TABLE 366. France Opioid Analgesics Market Size

Companies Mentioned

  • AbbVie Inc.
  • Akorn Inc.
  • Alembic Pharmaceuticals Ltd
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Cadila Healthcare Ltd
  • Collegium Pharmaceutical Inc.
  • Daiichi Sankyo Company, Limited
  • Dr. Reddy’s Laboratories Ltd
  • Endo International plc
  • GlaxoSmithKline plc
  • Grünenthal GmbH
  • Hikma Pharmaceuticals plc
  • Johnson & Johnson
  • Lupin Limited
  • Mallinckrodt Pharmaceuticals plc
  • Mayne Pharma Group Ltd
  • Mundipharma Pharmaceuticals
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi SA
  • Sterling Pharma Solutions (UK) Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zoetis Inc.

Related Topics

Related Reports

Global Opioids - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Global Opioids - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 125 Pages
  • Global
From
Opioids Market - Global Forecast 2026-2032 - Product Image

Opioids Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Acetaminophen-Opioid Combination Market - Global Forecast 2026-2032 - Product Image

Acetaminophen-Opioid Combination Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From
Acetaminophen-Opioid Combination Market Report 2026 - Product Image

Acetaminophen-Opioid Combination Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.